Does PAZOPANIB Cause Decreased appetite? 1,116 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 1,116 reports of Decreased appetite have been filed in association with PAZOPANIB (Pazopanib). This represents 5.3% of all adverse event reports for PAZOPANIB.
1,116
Reports of Decreased appetite with PAZOPANIB
5.3%
of all PAZOPANIB reports
196
Deaths
321
Hospitalizations
How Dangerous Is Decreased appetite From PAZOPANIB?
Of the 1,116 reports, 196 (17.6%) resulted in death, 321 (28.8%) required hospitalization, and 52 (4.7%) were considered life-threatening.
Is Decreased appetite Listed in the Official Label?
Yes, Decreased appetite is listed as a known adverse reaction in the official FDA drug label for PAZOPANIB.
What Other Side Effects Does PAZOPANIB Cause?
Death (3,767)
Diarrhoea (2,907)
Fatigue (1,883)
Nausea (1,879)
Malignant neoplasm progression (1,471)
Drug ineffective (1,135)
Vomiting (1,072)
Hypertension (1,004)
Malaise (764)
Disease progression (739)
What Other Drugs Cause Decreased appetite?
ADALIMUMAB (6,135)
LENALIDOMIDE (5,103)
SEMAGLUTIDE (4,317)
METHOTREXATE (4,229)
CABOZANTINIB S-MALATE (4,076)
APREMILAST (3,442)
RITUXIMAB (3,438)
PALBOCICLIB (3,400)
PREDNISONE (3,390)
LENVATINIB (3,257)
Which PAZOPANIB Alternatives Have Lower Decreased appetite Risk?
PAZOPANIB vs PEANUT
PAZOPANIB vs PEG INTERFERON
PAZOPANIB vs PEG-INTERFERON ALFA 2A
PAZOPANIB vs PEGASPARGASE
PAZOPANIB vs PEGASYS